Furthermore, GCN2 protein levels are markedly reduced in the pulmonary endothelium of patients with pulmonary fibrosis and associated pulmonary hypertension, independent of PH severity. This evidence concerns the gene EIF2AK4 and pulmonary arterial hypertension.